tm logo
JAYPIRCA
ADVERTISED

on 20 Nov 2024

Last Applicant/ Owned by

Eli Lilly and Company

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

2148689 filed on 19th Nov 2021

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

JAYPIRCA

Trademark usage description

(1) pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, atopic dermatitis, autoimmune d Read More

Classification Information


Class [005]
(1) Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, osteoarthritis, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; vascular diseases; Diagnostic agents, preparations and substances for medical diagnostic purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.


Classification kind code

12

Mark Details


Serial Number

2148689

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 20th Nov 2024
Advertised
Submitted for opposition 27
on 28th Oct 2024
Approval Notice Sent
Submitted for opposition 26
on 28th Oct 2024
Approved
Submitted for opposition 22
on 18th Oct 2024
Search Recorded
Submitted for opposition 287
on 12th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 48
on 01st Feb 2022
Agent Changed
Submitted for opposition 30
on 19th Nov 2021
Filed
Submitted for opposition 1
on 19th Nov 2021
Created
Submitted for opposition 31
on 19th Nov 2021
Formalized